INKON Life Technology Co Ltd

INKON Life Technology Co Ltd maintains a market capitalization of 8.21 billion CNY and a price-to-earnings ratio of 119.73, indicating a high valuation relative to earnings. The company's price-to-book ratio of 3.27 suggests that the market values the company at a premium to its book value. The enterprise value to EBITDA ratio of 55.79 reflects a high multiple, which may indicate investor optimism or a premium valuation relative to earnings before interest, taxes, depreciation, and amortization. The company's liquidity position is characterized by a current ratio of 2.07, suggesting it has sufficient short-term assets to cover its short-term liabilities. The company's profitability is modest, with a return on equity of 2.73% and a return on assets of 1.63%, both below the industry median for healthcare facilities and services. The gross profit margin of 26.93% (507.74 million CNY gross profit on 1.89 billion CNY revenue) is in line with industry norms, but the operating margin of 8.54% (160.91 million CNY operating income) is relatively low. The net profit margin of 3.64% (68.54 million CNY net income) indicates that the company is generating a small net return on its revenue. INKON Life Technology Co Ltd's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. The company's revenue concentration in a single segment increases its exposure to sector-specific risks, such as regulatory changes or market demand fluctuations. The company's revenue growth trajectory is not explicitly provided, but the free cash flow of -40.64 million CNY and capital expenditure of -226.64 million CNY suggest that the company is investing in its operations. The operating cash flow of 340.83 million CNY indicates that the company is generating positive cash flow from its operations. The company's capital expenditure is a significant portion of its operating cash flow, suggesting a focus on growth and expansion. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The debt-to-equity ratio of 0.31 indicates a relatively low level of leverage, which reduces financial risk. However, the company's net cash position is negative after subtracting total debt, which may indicate a need for additional financing. The company's liquidity position is supported by a current ratio of 2.07, which suggests it has sufficient short-term assets to cover its short-term liabilities. Recent events and disclosures indicate that the company is subject to analyst estimates, with a mean price target of 12.42 CNY and a mean recommendation of 1.00 (strong buy). The company has not disclosed any recent filings or transcripts that would provide additional insight into its operations or strategic direction.